Target intelligence / Profile preview

LIX1 and RIOK2 antisense RNA 1 (LIX1-AS1)

Target
LIX1-AS1
Molecular classification
Long non-coding RNA (lncRNA), Antisense RNA
01

Overview

LIX1 and RIOK2 antisense RNA 1 (LIX1-AS1) is a long non-coding RNA (lncRNA) located on human chromosome 5q15, spanning the region 5:97089075-97439742. As an antisense RNA, LIX1-AS1 is classified among regulatory RNAs that can modulate gene expression through various mechanisms including chromatin modification, regulation of RNA stability, and transcriptional interference. These long non-coding antisense RNAs can influence their associated sense genes by different methods such as direct stabilization of mRNAs, alteration of methylation states in promoter regions, or acting as scaffolds for chromatin-modifying proteins. However, there is currently no direct evidence in the provided search results that LIX1-AS1 itself is a drug target or receptor, nor are there specific drugs, biomarkers, or notable safety concerns reported for this lncRNA. For practical purposes, LIX1-AS1 is best categorized as a non-protein-coding regulatory RNA with potential biological importance in gene regulation, but without sufficient information for clinical targeting or disease associations at this time.

Other names
LIX1-AS1LIX1 and RIOK2 antisense RNA 1
02

Mechanism of action

Not applicable (no drugs directly targeting LIX1-AS1 identified).

03

Biological functions

Regulation of gene expression (through antisense mechanisms, possibly in cis or trans)Epigenetic regulation (potential modulation of neighboring gene promoters and chromatin state, as seen with other antisense lncRNAs)
04

Disease associations

No directly referenced disease associations specific to LIX1-AS1 found in current results; other lncRNA antisense RNAs are known to play roles in cancer and hematopoietic disease, but specific evidence for LIX1-AS1 is lacking in the provided results

Beyond the preview

Go deeper on LIX1 and RIOK2 antisense RNA 1 (LIX1-AS1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on LIX1 and RIOK2 antisense RNA 1 (LIX1-AS1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call